Clene Nanomedicine

Developer of therapeutics for the treatment of neurodegenerative diseases

placeSalt Lake City, Utah, United States calendar_todayFounded 2012 groups99 employees language clene.com

Registered entities

Investor mix

9 investors on record.

Investor typeCountShare
Venture capital333%
Private equity222%
Other / undisclosed444%
Coming soon